Abiopharma

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of agilon health, inc.(AGL) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc(PRGO) Shareholders

Integer Holdings Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ITGR

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion

World-Renowned Alzheimers Expert Prof. Steven Arnold Joins NeuroSense SAB

Biofrontera Notification (BFRI)

VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

(10% Negative) Xilio Therapeutics, Inc. (XLO) Announces Delay in million Trials for gross proceeds from Series B warrant exercises Due to Geopolitical Situation, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) ARDELYX, INC. (ARDX) Reports Q1 2026 Financial Results

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

(99% Neutral) SELLAS Life Sciences Group, Inc. (SLS) Reports Q1 2026 Financial Results

(99% Neutral) Alaunos Therapeutics, Inc. (TCRT) Announces Clinical Development Update

RenovoRx To Announce Promising New Clinical Data Using itsTAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026